Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Potassium-Competitive Acid Blocker-Bismuth Quadruple Therapy for Second-Line Helicobacter Pylori Eradication

NCT07855497 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT07855497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07855497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Potassium-Competitive Acid Blocker-Bismuth Quadruple Therapy for Second-Line Helicobacter Pylori Eradication
Lead sponsor
Seoul National University Bundang Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2021
Completion date
September 28, 2027
Enrollment
141 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infections